Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",48551,293,1.22 [1.02-1.45],0.0259973182950852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49770,2718,1.14 [1.08-1.21],7.246623066672054e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,50328,830,1.16 [1.04-1.29],0.0061445625235555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48799,6862,1.11 [1.07-1.15],2.61570628290668e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49002,6268,1.13 [1.09-1.17],8.907042586438114e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49832,2387,1.14 [1.07-1.22],2.4815088105501023e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46309,1888,1.19 [1.11-1.27],1.4844430673599303e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44749,2154,1.22 [1.14-1.30],2.492567916347268e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44502,496,1.23 [1.08-1.41],0.0023297719950488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35357,3873,1.12 [1.07-1.18],7.175455181416135e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44203,768,1.24 [1.12-1.38],6.829078773383857e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,50255,2810,1.12 [1.06-1.18],0.0001583689149088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,50477,979,1.17 [1.06-1.29],0.001629688893044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48880,1828,1.16 [1.08-1.25],3.744285402883989e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50345,2087,1.17 [1.10-1.25],3.3381239031571312e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50081,1823,1.17 [1.09-1.26],1.3004325270791107e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50420,308,1.28 [1.08-1.51],0.0041039054848829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50383,271,1.23 [1.03-1.48],0.0235680232112165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47874,822,1.17 [1.06-1.30],0.0030681314950742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47660,215,1.39 [1.15-1.69],0.0008173075617062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50366,121,1.35 [1.04-1.75],0.0241050838426321
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of meninges,50550,113,1.42 [1.09-1.85],0.0098533318600781
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50444,128,1.41 [1.10-1.81],0.0072120793204396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,50529,212,1.37 [1.13-1.67],0.0015734196521194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lung cancer and mesothelioma,35065,646,1.30 [1.16-1.47],8.212875446771322e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lymphoid leukaemia,40293,102,1.60 [1.23-2.08],0.0004873328634084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40399,208,1.28 [1.04-1.57],0.0201609819136376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40336,145,1.44 [1.14-1.82],0.0019767602775248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46888,221,1.57 [1.31-1.89],8.62818075971159e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,49473,136,1.34 [1.05-1.72],0.0205645803664336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49023,5664,1.14 [1.10-1.19],1.2842076653800628e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49632,2965,1.14 [1.07-1.20],8.89614351767673e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49630,2963,1.14 [1.07-1.20],9.514097167374032e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49939,2343,1.30 [1.22-1.38],1.904475408267206e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",50115,441,0.82 [0.70-0.96],0.0116713232354612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39153,624,1.30 [1.15-1.46],2.025428327547101e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",49640,1110,1.10 [1.00-1.21],0.0485695275700958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49881,3057,1.20 [1.13-1.26],8.986537402086885e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44061,2966,1.21 [1.15-1.28],8.9194825078602e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39085,556,1.24 [1.09-1.41],0.0010848997672081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45420,6891,1.15 [1.11-1.19],5.846857444842879e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,38909,380,1.18 [1.01-1.38],0.0379874949816344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39616,1087,1.21 [1.10-1.32],7.51004194702557e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50415,643,1.24 [1.10-1.39],0.0003625633007135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50048,276,1.38 [1.16-1.64],0.0002469816746651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49515,3049,1.11 [1.05-1.17],0.0002875679139724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39035,506,1.29 [1.13-1.48],0.0001736517143077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39110,581,1.37 [1.21-1.55],3.724507817095915e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39774,1245,1.15 [1.05-1.26],0.0016835497524427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50031,259,1.36 [1.13-1.62],0.0008552835090436
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,48247,9718,1.12 [1.09-1.16],1.402326938713416e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,49904,2382,1.09 [1.02-1.16],0.0077067150801945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41631,3102,1.15 [1.09-1.22],5.413405863133222e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50552,440,1.32 [1.15-1.52],7.679059650588082e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,47801,279,1.26 [1.06-1.51],0.0096069400305427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",38861,332,1.21 [1.02-1.43],0.0273279026402294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46014,300,1.53 [1.31-1.80],1.283908834731905e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4152,167,1.31 [1.03-1.65],0.0245845065627292
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45838,124,1.63 [1.28-2.08],6.536673121842532e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49323,3609,1.38 [1.32-1.45],5.972762091944963e-41
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40035,1506,1.21 [1.12-1.31],1.78855274802082e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48360,321,1.23 [1.04-1.45],0.0163353508822578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,46190,2344,1.22 [1.15-1.30],3.4456108047415487e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,48154,115,1.38 [1.06-1.80],0.0151428805923577
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48428,389,1.44 [1.25-1.66],3.571379532881659e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,28026,374,1.21 [1.03-1.41],0.0183347594002718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47886,4076,1.20 [1.14-1.25],1.2498399523213193e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44119,14794,1.06 [1.03-1.08],3.722745701125003e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50173,2143,1.18 [1.11-1.26],4.351281049160702e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,45916,12713,1.08 [1.05-1.11],5.658039088050504e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45953,12750,1.08 [1.05-1.11],2.0362995845772172e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33546,343,1.38 [1.18-1.61],3.807483242293819e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33475,272,1.74 [1.49-2.04],4.889826362081169e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,50294,2294,1.09 [1.02-1.16],0.0083510665304702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",48221,4375,1.17 [1.11-1.22],7.343112598780426e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49841,1085,1.21 [1.10-1.33],4.045786630305771e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49636,1640,1.15 [1.06-1.24],0.0003388546598178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45229,1383,1.22 [1.13-1.33],7.080361556380706e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50393,301,1.35 [1.15-1.59],0.0003415419134678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",50519,603,1.17 [1.03-1.32],0.0134189491818159
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,42620,828,1.15 [1.04-1.28],0.0081246137158579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48234,195,1.42 [1.16-1.73],0.0005208638406505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48500,461,1.26 [1.10-1.44],0.0010121388114411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43812,2020,1.12 [1.04-1.20],0.0014133701469519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49106,1067,1.21 [1.10-1.32],4.953482564774543e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49356,674,1.17 [1.04-1.31],0.0094932221958148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",48854,1206,1.14 [1.04-1.25],0.0036131139405007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48774,795,1.39 [1.26-1.53],7.844988400042247e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49345,663,1.17 [1.04-1.32],0.0078996599004861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49818,1246,1.18 [1.08-1.29],0.0001579276001624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49777,1317,1.19 [1.09-1.29],5.70934755552011e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49211,455,1.26 [1.09-1.45],0.0011982564922885
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48504,508,1.23 [1.08-1.41],0.0018173707543946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50339,704,0.75 [0.66-0.85],4.401471163093342e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44247,2810,1.13 [1.07-1.20],4.060890446158681e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,49300,7863,1.13 [1.09-1.17],3.3386881522905188e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50248,833,0.76 [0.68-0.85],3.082080505807507e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44551,3114,1.21 [1.15-1.28],1.886065328256547e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,49539,2692,1.29 [1.23-1.36],3.614016418747805e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44645,3208,1.15 [1.09-1.21],1.2213476802801046e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47882,961,1.14 [1.03-1.26],0.0097439136141128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49630,2671,1.09 [1.02-1.16],0.005849773896326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,50538,139,1.38 [1.08-1.75],0.0095297756489341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47076,155,1.29 [1.02-1.63],0.0333444255889786
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49260,2339,1.09 [1.02-1.16],0.0089632384665706
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,47674,7389,1.05 [1.02-1.09],0.0052184571441447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47729,808,1.17 [1.05-1.30],0.0040683895515943
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50431,579,1.26 [1.11-1.42],0.0002745322550629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50232,460,1.34 [1.17-1.53],2.656025760001185e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4107,122,1.32 [1.01-1.73],0.0400184809042029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50153,2016,1.10 [1.02-1.18],0.0089981559154232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49364,357,0.80 [0.67-0.95],0.0118856415152262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47451,4259,1.06 [1.01-1.12],0.0128987640405664
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48371,234,1.28 [1.05-1.55],0.0132959306894458
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,46721,3529,1.07 [1.01-1.13],0.0142242403631054
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50324,254,1.28 [1.07-1.54],0.0076635337274316
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50378,1760,1.13 [1.05-1.22],0.0010994671108778
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,49879,1261,1.15 [1.05-1.25],0.0018618422757172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37349,3450,1.06 [1.00-1.12],0.0342328766401353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37819,3400,1.06 [1.00-1.12],0.0350106590736152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),49782,269,1.25 [1.05-1.50],0.014298595950358
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",46561,160,1.43 [1.15-1.78],0.0014010527917884
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bronchiectasis,43846,691,1.20 [1.07-1.35],0.0015206995302281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43269,114,1.34 [1.03-1.75],0.0320438778835001
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48591,5436,1.08 [1.04-1.13],0.0002964142090072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,48042,301,1.27 [1.07-1.50],0.0061991296097215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",50181,2326,1.08 [1.02-1.15],0.013418275124308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46528,10289,1.09 [1.06-1.12],5.824934436074424e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,48468,613,1.17 [1.04-1.32],0.0073843103014757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Emphysema,43763,608,1.34 [1.19-1.50],5.812241584438686e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48046,556,1.32 [1.17-1.50],7.465495742063919e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50145,3744,1.13 [1.07-1.18],3.661031140895296e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,48112,622,1.32 [1.17-1.48],3.84985197606185e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50081,1899,1.16 [1.09-1.25],1.9841626574879504e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,50111,3895,1.09 [1.04-1.14],0.0008462533721767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50396,773,1.30 [1.17-1.45],7.809722131318652e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50366,2542,1.11 [1.04-1.18],0.0011065739167538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49649,3248,1.14 [1.08-1.20],2.4900458576219565e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,49749,126,1.41 [1.10-1.81],0.0073156482190218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50038,1856,1.15 [1.07-1.24],7.639211371138312e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute gastritis,38078,180,1.33 [1.08-1.65],0.0083518115668119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,48828,141,0.73 [0.55-0.96],0.0258370905779004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46807,201,1.48 [1.21-1.79],8.870214101873012e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49757,201,1.46 [1.20-1.78],0.0001529684231692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,48548,1942,1.20 [1.12-1.28],2.446386570840827e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,47437,242,1.35 [1.12-1.62],0.0013002442603316
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,50071,3276,1.07 [1.01-1.13],0.019821021050815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,47303,184,1.34 [1.08-1.65],0.0065956584126205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47292,173,1.40 [1.13-1.74],0.0018072154429134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45374,4359,1.07 [1.02-1.12],0.0046729365729704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46321,8423,1.06 [1.02-1.09],0.0012653589616058
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50411,923,1.12 [1.01-1.24],0.0281049476809551
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49963,2768,1.07 [1.01-1.14],0.0194478961916938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49351,2745,1.14 [1.08-1.21],6.824626871460929e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,41802,6189,1.06 [1.02-1.11],0.0027840104734411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,38287,389,1.19 [1.02-1.38],0.0293371549805527
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,38975,1077,1.11 [1.01-1.22],0.0336518565031303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,42783,4885,1.06 [1.01-1.11],0.0108350542284433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38955,1057,1.11 [1.01-1.22],0.0296331327239061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39165,16222,1.06 [1.03-1.08],9.697348203234072e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,47388,6373,1.05 [1.01-1.10],0.0105146520132469
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impaction of intestines,35724,111,1.33 [1.01-1.76],0.0405178321026892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47477,282,1.36 [1.14-1.61],0.0004445380437522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,50517,724,1.16 [1.04-1.30],0.0097762249133633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48607,1488,1.19 [1.10-1.28],1.9729806886334864e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49092,1973,1.15 [1.08-1.23],4.855815329964907e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,39081,1183,1.11 [1.01-1.21],0.0254486087543698
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38267,2654,1.10 [1.03-1.17],0.0023218490668104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47159,553,1.17 [1.03-1.33],0.0188622258431438
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,46654,11041,1.06 [1.03-1.09],0.000299748031149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39192,1294,1.11 [1.02-1.21],0.0194816131492131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50282,794,1.13 [1.01-1.26],0.0287226770838828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39759,1861,1.09 [1.01-1.17],0.0267499520082403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,38977,3364,1.08 [1.02-1.14],0.0074354175826564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41814,3916,1.09 [1.04-1.14],0.0008554618902129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48849,1730,1.16 [1.08-1.25],7.8852212280264e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36287,674,1.13 [1.00-1.27],0.0417331861710517
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,47432,313,1.23 [1.04-1.46],0.014720374779584
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Volvulus,35771,158,0.76 [0.58-0.99],0.0426573352524319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47054,798,1.12 [1.00-1.25],0.0429410078504287
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50383,946,1.12 [1.02-1.24],0.0231352097630166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,49532,95,1.56 [1.18-2.06],0.0015393065103224
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46367,111,0.72 [0.52-0.98],0.0397625507073538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48347,372,1.21 [1.04-1.42],0.0147011687092022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50177,376,0.83 [0.70-0.99],0.0366638799639724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46714,458,1.30 [1.13-1.48],0.0001661565819072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46029,11040,1.03 [1.00-1.07],0.0280758517350019
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,42742,14219,1.04 [1.01-1.07],0.0056586880643122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,48750,5235,1.06 [1.02-1.11],0.006327814068927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43690,527,0.81 [0.70-0.94],0.0046522796231763
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,43593,430,1.23 [1.07-1.42],0.0044360198815662
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36171,1182,1.15 [1.05-1.26],0.0026199729064325
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50425,1166,1.13 [1.03-1.24],0.0071773786934264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44758,1243,1.10 [1.01-1.20],0.0286765484773199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44113,598,1.16 [1.02-1.32],0.0193647301066949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,46602,145,1.41 [1.12-1.78],0.0032217126382756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,49811,3354,0.94 [0.89-1.00],0.0361770462505216
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50296,883,1.15 [1.04-1.27],0.0083294263284297
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,39856,4867,1.06 [1.01-1.11],0.0115048226535018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,47203,746,0.88 [0.78-1.00],0.0422464589145202
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47063,3548,1.09 [1.03-1.14],0.0021447458620102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43358,195,1.40 [1.15-1.72],0.0010992954339837
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44929,1414,1.11 [1.03-1.21],0.0105688443685823
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45601,2438,1.13 [1.06-1.21],8.434646289268375e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38173,3184,1.12 [1.06-1.18],0.0001013641015682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44246,1083,1.11 [1.01-1.22],0.0333604656089534
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50318,856,1.15 [1.03-1.27],0.0104248473160784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,50532,104,1.35 [1.02-1.79],0.0371090074140447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44294,1131,1.11 [1.01-1.22],0.0240008238727354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43605,442,0.83 [0.71-0.97],0.0225277859234167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39861,4872,1.12 [1.07-1.17],8.540208795707763e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36270,1281,1.13 [1.03-1.23],0.0069744344848383
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35883,894,1.18 [1.07-1.31],0.0014072454686598
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44019,504,1.25 [1.09-1.43],0.0011017841465091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",50540,112,1.32 [1.00-1.73],0.047705362275213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,48195,5032,1.05 [1.01-1.10],0.0283903389276858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,46567,3052,1.07 [1.01-1.13],0.0271551717178974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45531,2016,1.10 [1.03-1.18],0.0077842077512519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48517,3086,1.23 [1.16-1.29],1.1931302037239365e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48438,3007,1.27 [1.20-1.34],1.5376970772221576e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50155,164,1.53 [1.24-1.89],9.319257128769492e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,50092,588,1.21 [1.07-1.37],0.0027519550536947
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dialysis,45590,159,1.87 [1.54-2.26],1.3613729675610196e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21291,1002,1.12 [1.01-1.23],0.029038934473591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42188,10506,1.07 [1.04-1.11],7.903168383427112e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,50158,167,1.41 [1.14-1.76],0.0018443109323216
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45413,572,1.23 [1.09-1.40],0.0010841732485185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21339,2552,1.07 [1.00-1.14],0.0395501145470165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44261,151,1.33 [1.05-1.68],0.0188659879614318
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48525,4415,1.09 [1.04-1.14],0.0005024801460573
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45508,1398,1.09 [1.00-1.18],0.0486682325636842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50441,937,1.31 [1.19-1.44],1.8568129594715017e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19068,281,1.21 [1.01-1.44],0.0402322128029061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47504,3394,1.11 [1.06-1.17],6.832507322708913e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45506,665,1.23 [1.09-1.38],0.0005280942681997
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49815,311,1.37 [1.16-1.61],0.0001495654171231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20452,163,1.33 [1.06-1.67],0.0134989399022757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50084,5243,1.19 [1.14-1.24],2.502217964881389e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49428,112,1.36 [1.04-1.78],0.0248657391959711
